GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Burning Rock Biotech
Burning Rock is a Chinese company specializing in cancer diagnostics based on next-generation sequencing (NGS). Its stock price reflects the enormous potential of this market in China, but also the intense competition and regulatory risks.
Share prices of companies in the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese oncology company offering genetic testing (liquid biopsy) for cancer diagnosis and treatment selection. We've classified it in the "Cancer Analysis" segment. The chart below shows the overall dynamics of the molecular diagnostics sector, which is revolutionizing cancer treatment.
Broad Market Index - GURU.Markets
Burning Rock Biotech is a Chinese company specializing in the development of cancer diagnostic tests based on next-generation sequencing. Its technological leadership makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Burning Rock compares to it.
Change in the price of a company, segment, and market as a whole per day
BNR - Daily change in the company's share price Burning Rock Biotech
Burning Rock Biotech's daily share price fluctuations reflect the extreme volatility inherent in biotech companies. This metric measures the company's sensitivity to news about the introduction of its cancer diagnostic tests, particularly in the Chinese market.
Daily change in the price of a set of shares in a market segment - Cancer analysis
Burning Rock Biotech's daily share price fluctuations reflect the extreme volatility inherent in biotech companies. This metric measures the company's sensitivity to news about the introduction of its cancer diagnostic tests, particularly in the Chinese market.
Daily change in the price of a broad market stock, index - GURU.Markets
Burning Rock Biotech specializes in cancer diagnostics using blood tests, a cutting-edge technology. Shares of such companies are extremely sensitive to research results and regulatory decisions. Each success or failure creates powerful impulses that feed into the overall market volatility picture depicted on this chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Burning Rock Biotech
Burning Rock Biotech Ltd.'s year-over-year performance tells the story of the Chinese oncology diagnostics market. Its 12-month market cap growth reflects demand for its tumor genetic profiling tests, which help select targeted therapies, as well as its success in early cancer detection, its key future bet.
Annual dynamics of market capitalization of the market segment - Cancer analysis
Burning Rock Biotech Limited is a leading Chinese company in sequencing-based cancer diagnostics. This chart illustrates how its technological leadership, dependence on the Chinese healthcare market, and strict regulatory environment impact its performance relative to the global biotech sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Burning Rock, a Chinese cancer diagnostics company, is betting on the growth of healthcare in China. Its share price (ADR) reflects both the long-term trend toward personalized medicine and the high regulatory and geopolitical risks associated with the Chinese market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in sequencing-based cancer diagnostics. Its monthly performance reflects growing hospital testing volumes and revenue from partnerships with pharmaceutical companies. China's regulatory environment is also a key factor.
Monthly dynamics of market capitalization of the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese company in the field of oncology diagnostics based on next-generation sequencing (NGS). Its tests help select targeted therapies. The company's growth depends on the implementation of NGS in clinical practice in China. The medical diagnostics sector's performance reflects the global trend toward personalized medicine, which Burning Rock is implementing in its market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Burning Rock Biotech is a Chinese company specializing in DNA-based cancer diagnostics. Its shares are traded in the US, but its business is focused on Asia. Its stock price performance is weakly correlated with the US market and heavily dependent on the adoption of its tests in Chinese hospitals and regulatory policies in China.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Burning Rock Biotech
Burning Rock, a Chinese company specializing in genetic cancer testing, whose weekly stock price reflects demand for precision medicine in China. Test volumes and regulatory changes in China shape short-term trends, revealing the pulse of this cutting-edge sector.
Weekly dynamics of market capitalization of the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in sequencing-based cancer diagnostics. This chart shows how its performance compares to the sector, reflecting both general oncology trends and the specific risks and opportunities associated with China's healthcare system and regulation.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Burning Rock Biotech is a Chinese cancer diagnostics company. Its success depends on the Chinese market and regulatory environment. The chart will show how its stock performance is detached from the US market, driven by specific news from China.
Market capitalization of the company, segment and market as a whole
BNR - Market capitalization of the company Burning Rock Biotech
The Burning Rock chart is a financial map of the liquid biopsy industry in China. The market capitalization of this company, which develops blood-based cancer diagnostic tests, reflects the demand for precision oncology in the vast Chinese market. Its dynamics are a barometer of its ability to commercialize its tests and compete with other players.
BNR - Share of the company's market capitalization Burning Rock Biotech within the market segment - Cancer analysis
Burning Rock Biotech's market share in oncology reflects its leadership in the Chinese liquid biopsy market. Its market share is driven by demand for its advanced DNA-based cancer diagnostic and monitoring tests, making it a key player in personalized medicine in Asia.
Market capitalization of the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in genetic testing for cancer diagnostics. The chart below shows the overall market capitalization of the entire biotech sector. Its dynamics reflect the global trend toward precision medicine in oncology.
Market capitalization of all companies included in a broad market index - GURU.Markets
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. Its market capitalization reflects its leadership in this field in China. The chart below shows the economic weight of Asia's cancer diagnostics leaders.
Book value capitalization of the company, segment and market as a whole
BNR - Book value capitalization of the company Burning Rock Biotech
For Burning Rock Biotech, a cancer diagnostics company, its book value is its cutting-edge laboratories in China. The chart below shows how the company is investing in its scientific and technological arsenal. Growth in this arsenal means building the material foundation for leadership in the oncology diagnostics market.
BNR - Share of the company's book capitalization Burning Rock Biotech within the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in sequencing-based cancer diagnostics. Its core business is its cutting-edge laboratories. The asset share chart shows how the company invests in its unique and capital-intensive physical infrastructure.
Market segment balance sheet capitalization - Cancer analysis
Burning Rock is an oncology diagnostics company. Its value lies in its technology and data, and its tangible assets are large centralized laboratories in China. The graph will show whether this "lightweight," science-driven model is typical for the entire diagnostics sector.
Book value of all companies included in the broad market index - GURU.Markets
Burning Rock Balance is China's leading laboratory providing next-generation sequencing (NGS) services for cancer diagnostics and targeted therapy. The company's assets include its cutting-edge equipment and databases, which form the foundation of personalized oncology in the country.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in cancer genetic testing (liquid biopsy). Its value lies in its technology and database. Its market capitalization reflects its leadership in the Chinese market and its potential for early cancer detection. The chart shows the promise of this cutting-edge field of medicine.
Market to book capitalization ratio in a market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. Its value lies in its technology and data. The chart shows the high premium the market pays for its leadership in the vast Chinese cancer diagnostics market.
Market to book capitalization ratio for the market as a whole
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. The chart shows the market valuation of this leader in precision oncology in China. Its high market capitalization is based on its cutting-edge technology, not on laboratory costs, and on the enormous potential of the Chinese healthcare market.
Debts of the company, segment and market as a whole
BNR - Company debts Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. This business requires significant investment in R&D, lab equipment, and test validation. This chart shows how the company finances its technological leadership in the market.
Market segment debts - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in cancer diagnostics based on next-generation sequencing (NGS). "Liquid biopsy" is a breakthrough in oncology. The chart shows the financial norms for the biotech sector, against which Burning Rock is raising capital to expand its laboratories and commercialize its cutting-edge diagnostic tests.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. This is a cutting-edge and research-intensive field of medicine. This chart shows the company's use of debt to finance its laboratories, R&D, and commercial development in China, reflecting its growth strategy.
Market segment debt to market segment book capitalization - Cancer analysis
The development of blood-based cancer diagnostic tests (liquid biopsies), like Burning Rock's, is at the cutting edge of medicine. This chart shows how the biotech sector is funding such innovations. It allows us to assess how capital-intensive this technology is and how the Chinese company's financial model compares to its Western competitors in this promising market.
Debt to book value of all companies in the market
Burning Rock Biotech specializes in next-generation sequencing-based cancer diagnostics in China. Medical diagnostics require investment in laboratories and advanced equipment. The chart helps understand how their debt burden, despite being a technology leader, compares to the global market.
P/E of the company, segment and market as a whole
P/E - Burning Rock Biotech
This chart shows the valuation of Burning Rock Biotech, a Chinese company specializing in genetic testing for cancer diagnosis and treatment. The metric reflects investors' confidence in the growth of the personalized oncology market in China and the company's technological leadership in this field.
P/E of the market segment - Cancer analysis
This chart shows the average valuation for genetic diagnostics companies in Asia, similar to Burning Rock Biotech. This metric reflects investor confidence in the growth of the personalized oncology market in the region. It serves as a benchmark for evaluating Burning Rock against other players in the Chinese market.
P/E of the market as a whole
Burning Rock Biotech is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). It provides tests for targeted therapy selection. This chart reflects global trends in medicine and helps understand the market discounting the company's valuation due to regulatory and competitive risks associated with operating primarily in China.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based oncology diagnostics, providing tests for targeted therapies. Future growth depends on the adoption of its tests in China. This chart shows investor expectations for the growth of the personalized oncology market in China and the company's leadership in this field.
%20P%2FE%20Burning%20Rock%20Biotech&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Burning-Rock-Biotech&v=1772630816722 "Chart of the company's future (projected) P/E Burning Rock Biotech")
Future (projected) P/E of the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese company in oncology diagnostics based on next-generation sequencing (NGS). Its tests help personalize therapies for cancer patients. This chart reflects expectations for the biotech sector, helping to understand how the market views this technology leader in the vast Chinese market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Cancer-analysis&v=1772630816800 "Future (projected) P/E graph of the market segment - Cancer analysis")
Future (projected) P/E of the market as a whole
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. Their tests help select personalized therapies. This global outlook is influencing healthcare investment. Market optimism is driving the adoption of advanced medical technologies, such as NGS diagnostics, into clinical practice.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772630816848 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Burning Rock Biotech
Burning Rock Biotech is a leading Chinese company in oncology diagnostics based on next-generation sequencing (NGS). This chart shows growth in the precision medicine sector. Revenue depends on the number of tests sold for cancer detection and treatment selection, as well as partnerships with pharmaceutical companies.
Profit of companies in the market segment - Cancer analysis
Ebang International Holdings is a Chinese manufacturer of Bitcoin mining hardware (ASIC miners). Its profitability is entirely dependent on demand for mining equipment, which is directly correlated with the price of Bitcoin. This chart reflects the highly cyclical and speculative nature of this business, which is closely tied to the cryptocurrency market.
Overall market profit
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. The company provides tests for targeted therapy. Its growth reflects the adoption of personalized medicine in China and is an indicator of the development of advanced technologies in the country's healthcare system.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). Its profit forecast depends on the clinical adoption of its tests in China. This chart shows analysts' expectations for the growth of the precision oncology market in China and Burning Rock's leadership.
%20profit%20of%20the%20company%20Burning%20Rock%20Biotech&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Burning-Rock-Biotech&v=1772630816993 "Graph of future (projected) profit of the company Burning Rock Biotech")
Future (predicted) profit of companies in the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). The company's tests help select personalized therapies for cancer patients. This chart shows profitability forecasts for the medical diagnostics sector, reflecting the rapid growth and potential of genetic testing in oncology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Cancer-analysis&v=1772630817044 "Graph of future (predicted) profits of companies in a market segment - Cancer analysis")
Future (predicted) profit of the market as a whole
Burning Rock Biotech specializes in cancer diagnostics based on next-generation sequencing. Demand for its services is driven by oncology needs and healthcare budgets. The overall corporate profit forecast, as shown in this chart, can influence public and private spending on advanced medical technologies and the investment climate in the sector.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772630817086 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in next-generation sequencing (NGS) for cancer diagnostics and monitoring. Its revenue comes from fees for genetic testing. The chart shows how the market views its leadership in liquid biopsy in the vast Chinese market, betting on the growth of personalized oncology.
P/S market segment - Cancer analysis
Burning Rock Biotech Limited is a leading Chinese precision oncology company offering a wide range of next-generation sequencing (NGS)-based tests for cancer diagnosis and treatment. This chart shows the average market value for the sector, providing insight into how the market appreciates Burning Rock's technological leadership in China.
P/S of the market as a whole
Burning Rock Biotech is a Chinese company specializing in cancer diagnostics based on next-generation sequencing (NGS). The company's tests help select personalized therapies. This chart, showing average valuations, clearly demonstrates the premium investors place on the revenue of this company operating at the forefront of cancer diagnostics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Burning Rock Biotech
Burning Rock Biotech specializes in developing next-generation sequencing (NGS)-based oncology tests for early diagnosis and targeted cancer therapy. This chart reflects investors' confidence in the future commercial success of its tests. The valuation is based on expectations for their widespread clinical adoption in China and beyond.
%20P%2FS%20Burning%20Rock%20Biotech&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Burning-Rock-Biotech&v=1772630817286 "The graph of the company's future (projected) P/S Burning Rock Biotech")
Future (projected) P/S of the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese precision oncology company. It offers genetic tumor testing for targeted therapy selection and early cancer detection. The chart below shows investors' estimates of Burning Rock's future revenue, reflecting the enormous potential of the oncology diagnostics market in China.
%20P%2FS%20market%20segment%20graph%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Cancer-analysis&v=1772630817325 "Future (projected) P/S market segment graph - Cancer analysis")
Future (projected) P/S of the market as a whole
This chart reflects the trend toward personalized medicine in oncology. Burning Rock Biotech, a Chinese company, specializes in genetic testing of tumors to select targeted therapies. Their growth demonstrates how advanced diagnostic methods are becoming the standard of care for cancer treatment, making it more accurate and effective.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772630817362 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Burning Rock Biotech
Burning Rock Biotech is a leading cancer diagnostics company in China. Its revenue is generated by sales of its next-generation sequencing (NGS)-based tests, which help doctors select targeted therapies for cancer patients. This chart reflects the rapid adoption of precision medicine in clinical practice in China.
Sales of companies in the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese oncology diagnostics company providing next-generation sequencing (NGS) services for targeted therapy selection. This chart shows total revenue in the oncology analysis sector. It reflects the revolution in cancer treatment based on tumor genetic analysis, where Burning Rock is a leader in the Asian market.
Overall market sales
Burning Rock Biotech is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). It provides tests for treatment selection and early cancer detection. The company's growth depends on the adoption of its tests in clinical practice. This overall economic situation impacts healthcare costs and the availability of advanced diagnostics.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Burning Rock Biotech
Burning Rock Biotech is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). It offers tests for cancer detection and treatment selection. The chart shows analyst revenue forecasts, reflecting their expectations for the growth of the oncology genetic testing market in China.
%20sales%20of%20the%20company%20Burning%20Rock%20Biotech&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Burning-Rock-Biotech&v=1772630817458 "Schedule of future (projected) sales of the company Burning Rock Biotech")
Future (projected) sales of companies in the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese company in next-generation sequencing (NGS)-based oncology diagnostics. It offers tests for treatment selection and early cancer detection. This chart shows projected sales for the entire oncology diagnostics sector, reflecting analysts' expectations for growth in the personalized medicine market in Asia.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Cancer-analysis&v=1772630817492 "Schedule of future (projected) sales of companies in the market segment - Cancer analysis")
Future (projected) sales of the market as a whole
Burning Rock Biotech is a leading Chinese company specializing in next-generation sequencing (NGS)-based cancer diagnostics. Demand for its tests is driven by the adoption of personalized medicine in China. This economic downturn impacts healthcare costs and patient affordability, which determines the availability of advanced diagnostic tests.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772630817525 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Burning Rock Biotech
Burning Rock Biotech specializes in next-generation sequencing (NGS)-based cancer diagnostics in China. This metric reflects the commercialization of its cutting-edge technologies. It shows how successfully the company converts revenue from its diagnostic tests into net profit while managing R&D and lab costs.
Market segment marginality - Cancer analysis
Burning Rock Biotech is a leading Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). Profitability is driven by the volume of tests performed and their cost. This metric demonstrates the company's operational efficiency in China's advanced precision medicine market.
Market marginality as a whole
Burning Rock Biotech is a Chinese company specializing in the development of next-generation sequencing (NGS)-based cancer diagnostic tests. Their technology assists in the selection of targeted therapies. This overall profitability curve impacts them through healthcare budgets and patient affordability in China, on which the implementation of their cutting-edge tests depends.
Employees in the company, segment and market as a whole
Number of employees in the company Burning Rock Biotech
Burning Rock Biotech is a leading company in China in the field of next-generation sequencing (NGS)-based cancer diagnostics. This chart illustrates its scientific and commercial scale. The growth of its team of scientists, laboratory technicians, and sales specialists reflects the rapid adoption of liquid biopsy and other advanced tests into clinical practice in China.
Share of the company's employees Burning Rock Biotech within the market segment - Cancer analysis
Burning Rock Biotech is a leading Chinese precision oncology company offering tests based on next-generation sequencing (NGS). This chart shows the percentage of geneticists and bioinformaticians the company employs in oncology diagnostics. Its team is at the forefront of the fight against cancer in China.
Number of employees in the market segment - Cancer analysis
Burning Rock Biotech Limited is a Chinese company specializing in the development and commercialization of next-generation sequencing (NGS)-based tests for cancer diagnostics and monitoring. This chart shows overall employment in the oncology testing sector. It illustrates the rapid development of personalized medicine in China, where Burning Rock is a leader.
Number of employees in the market as a whole
Burning Rock Biotech is a Chinese company specializing in cancer diagnostics based on next-generation sequencing (NGS). Its tests help select personalized therapies. This graph illustrates the labor market, where personalized medicine is one of the fastest-growing sectors, creating a demand for geneticists, bioinformaticians, and highly skilled laboratory technicians.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Burning Rock Biotech (BNR)
Burning Rock Biotech is a leading Chinese company in the field of oncology diagnostics based on next-generation sequencing (NGS). This chart shows how the market values this knowledge-intensive business. The high market capitalization per employee suggests that the company's value lies in its technologies, patents, and databases, not in the number of lab technicians.
%20of%20the%20company%20Burning%20Rock%20Biotech%20(BNR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Burning-Rock-Biotech-BNR&v=1772630817757 "Chart of market capitalization per employee (in thousands of dollars) of the company Burning Rock Biotech (BNR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer analysis
Burning Rock Biotech specializes in cancer diagnostics based on next-generation sequencing (NGS). It is a high-tech company in the field of medical diagnostics. This metric reflects the value of their technologies and patents. Their high market capitalization per employee indicates that the market highly values their scientific platform and its potential in oncology.
%20by%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Cancer-analysis&v=1772630817781 "Market capitalization per employee (in thousands of dollars) by market segment - Cancer analysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Burning Rock Biotech is a Chinese company specializing in genetic testing for cancer diagnosis and treatment. It is a knowledge-intensive healthcare business. The high valuation per employee reflects the growth potential of the precision oncology market in China and the value of its next-generation sequencing (NGS) technologies.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772630817815 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Burning Rock Biotech (BNR)
Burning Rock Biotech (BNR) is a Chinese company specializing in cancer diagnostics. Their core business is "liquid biopsy" (blood-based cancer testing) based on natural-cell sequencing (NGS). This is a high-tech laboratory service. This chart shows how much net profit (or loss) each lab technician and scientist generates.
%20Chart%20Burning%20Rock%20Biotech%20(BNR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Burning-Rock-Biotech-BNR&v=1772630817847 "Company Profit Per Employee (in thousands of dollars) Chart Burning Rock Biotech (BNR)")
Profit per employee (in thousands of dollars) in the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in cancer diagnostics based on next-generation sequencing. In the medical diagnostics sector, this metric reflects laboratory efficiency. The schedule sets the bar. BNR's profitability per employee depends on the level of automation, which allows it to process thousands of samples with minimal manual labor.
%20in%20the%20market%20segment%20-%20Cancer%20analysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Cancer-analysis&v=1772630817865 "Chart of profit per employee (in thousands of dollars) in the market segment - Cancer analysis")
Profit per employee (in thousands of dollars) for the market as a whole
Burning Rock (BNR) is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS). They provide cancer detection tests. This metric reflects the profitability of their high-tech laboratory. It shows how much profit each lab technician and scientist generates from each test sold.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772630817894 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Burning Rock Biotech (BNR)
This chart for Burning Rock Biotech, a company specializing in next-generation sequencing-based cancer diagnostics, shows the commercialization of its tests. The growth in revenue per employee indicates the growing adoption of its assays in clinical practice in China.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Burning-Rock-Biotech-BNR&v=1772630817917 "Sales chart per company employee Burning Rock Biotech (BNR)")
Sales per employee in the market segment - Cancer analysis
Burning Rock Biotech is a Chinese company specializing in liquid biopsy and NGS testing for cancer diagnosis and treatment. This metric reflects the average revenue per employee by segment. It helps assess how productive Burning Rock's team is in commercializing its cutting-edge diagnostic tests in the Chinese market.
Sales per employee for the market as a whole
Burning Rock Biotech (BNR) is a Chinese company specializing in sequencing-based (NGS) oncology diagnostics, including liquid biopsy. This metric reflects the commercialization of their tests. The growth in revenue per employee (scientist, lab technician) indicates that their innovative (and expensive) tests are increasingly being adopted in oncology in China.
Short shares by company, segment and market as a whole
Shares shorted by company Burning Rock Biotech (BNR)
Burning Rock Biotech is a Chinese company specializing in sequencing-based cancer diagnostics (NGS). This market in China is becoming increasingly competitive. This chart reflects investor bets that the company will not be able to withstand a price war, as well as general risks associated with China's regulatory environment and reporting transparency.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Burning-Rock-Biotech-BNR&v=1772630818052 "Short Shares Chart for the Company Burning Rock Biotech (BNR)")
Shares shorted by market segment - Cancer analysis
Burning Rock (BNR) is a Chinese company specializing in oncology diagnostics based on next-generation sequencing (NGS) for early cancer detection. This chart shows the overall short position in the oncology diagnostics sector. It reflects investor skepticism about the Chinese biotech market, competition, and reimbursement system.
Shares shorted by the overall market
Burning Rock (BNR) is a Chinese biotech company (in cancer diagnostics). This business carries a dual risk. When this *global* pessimism indicator rises, investors (1) flee emerging markets (like China) and (2) sell off unprofitable biotechs, fearing the risks of financing.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Burning Rock Biotech (BNR)
For Burning Rock Biotech, this chart is a barometer of the Chinese oncology diagnostics market. The company specializes in liquid biopsy (blood-based cancer testing). Rapid growth in the number of tests and partnerships with pharmaceutical companies in China are pushing the oscillator into overbought territory (above 70). Fierce competition, pricing pressure, and regulatory risks in Chinese healthcare are leading to oversold territory.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Burning-Rock-Biotech-BNR&v=1772630818278 "RSI 14 indicator chart for the company's stock Burning Rock Biotech (BNR)")
RSI 14 Market Segment - Cancer analysis
Burning Rock (BNR) is a "liquid biopsy" company from China. They are the *leaders* in *China* in *genetic testing* (NGS) for *cancer* and *blood analysis*. The "Cancer Analysis" sector (biotech/diagnostics) thrives on R&D. RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is BNR's growth a "Chinese" niche or just general hype?
RSI 14 for the overall market
Burning Rock (BNR), a Chinese cancer diagnostics company. This chart reflects risk appetite cubed: it's "risky" China, "risky" biotech. In euphoria, investors are willing to buy into the "dream." In panic, capital flees from such speculative ventures first.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BNR (Burning Rock Biotech)
Burning Rock is a Chinese biotech company specializing in "liquid biopsy"—a cancer screening (NGS) performed on blood samples to determine therapy. This chart shows the average price target from analysts, which balances their assessment of the diagnostics market growth in China with significant geopolitical risks.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BNR-Burning-Rock-Biotech&v=1772630818462 "A chart showing analyst consensus forecasts for the expected stock price. BNR (Burning Rock Biotech)")
The difference between the consensus estimate and the actual stock price BNR (Burning Rock Biotech)
Burning Rock (BNR) is a leading Chinese biotech company in the field of "liquid biopsy" (blood-based cancer testing). This chart is a barometer of Chinese biotech. It measures the gap between the price (low due to risks) and the consensus target, reflecting the high potential (and risk) analysts see in their diagnostic platform in China.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BNR-Burning-Rock-Biotech&v=1772630818555 "A chart showing the difference between the consensus forecast and the actual stock price. BNR (Burning Rock Biotech)")
Analyst consensus forecast for stock prices by market segment - Cancer analysis
Burning Rock Biotech is a Chinese company, a leader in liquid biopsy technology. Its tests detect cancer and tailor treatment based on blood samples. This chart shows analysts' overall expectations for the cancer testing sector. It reflects whether experts believe the non-invasive cancer diagnostics market in Asia will grow.
Analysts' consensus forecast for the overall market share price
Burning Rock Biotech is a Chinese company specializing in liquid biopsy (blood tests) for early cancer diagnosis and monitoring. This chart shows the overall sentiment of the *global* market. For Burning Rock, which operates in the healthcare sector but in a geopolitically risky jurisdiction (China), overall optimism is important, but investors weigh it against the specific risks of the region.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Burning Rock Biotech
Burning Rock is a cancer test company in China. They are one of the leaders in the Chinese liquid biopsy market—advanced genetic testing (NGS) that detects cancer from a blood sample. This chart is a barometer of Chinese MedTech. It reflects their ability to sell tests to hospitals and (importantly) their success in R&D partnerships with pharmaceutical companies, as well as the high regulatory risks in China.
AKIMA Market Segment Index - Cancer analysis
Burning Rock Biotech (BNR) specializes in next-generation sequencing (NGS)-based cancer diagnostics. The company offers tests for early detection and targeted therapies. The graph shows the segment average. It serves as a benchmark, allowing one to evaluate how Burning Rock compares to other diagnostic companies based on a combination of scientific and commercial factors.
The AKIM Index for the overall market
Burning Rock Biotech is a Chinese company, a leader in precision oncology (NGS testing) and early cancer detection. This chart, showing the average (global/US) market value, serves as a benchmark. It helps assess how BNR, a scientific story in an emerging market, compares to overall macroeconomic trends.
